1. Home
  2. PAGS vs BEAM Comparison

PAGS vs BEAM Comparison

Compare PAGS & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PAGS

PagSeguro Digital Ltd.

HOLD

Current Price

$11.42

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.28

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAGS
BEAM
Founded
2006
2017
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PAGS
BEAM
Price
$11.42
$27.28
Analyst Decision
Buy
Buy
Analyst Count
7
14
Target Price
$11.86
$46.00
AVG Volume (30 Days)
4.1M
2.1M
Earning Date
03-05-2026
02-24-2026
Dividend Yield
1.27%
N/A
EPS Growth
16.68
N/A
EPS
1.37
N/A
Revenue
$3,662,823,389.00
$55,701,000.00
Revenue This Year
$14.75
N/A
Revenue Next Year
$5.68
$22.06
P/E Ratio
$8.03
N/A
Revenue Growth
10.88
N/A
52 Week Low
$6.70
$13.53
52 Week High
$12.32
$36.44

Technical Indicators

Market Signals
Indicator
PAGS
BEAM
Relative Strength Index (RSI) 59.26 45.52
Support Level $10.53 $24.30
Resistance Level $11.90 $29.26
Average True Range (ATR) 0.51 2.13
MACD -0.04 -0.64
Stochastic Oscillator 58.31 26.59

Price Performance

Historical Comparison
PAGS
BEAM

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: